D. E. Geller, Aerosol Antibiotics in Cystic Fibrosis, Respiratory Care, vol.54, issue.5, pp.658-670, 2009.
DOI : 10.4187/aarc0537

S. A. Novosad and A. Barker, Chronic obstructive pulmonary disease and bronchiectasis. Current opinion in pulmonary medicine 2013, pp.133-139

S. Marchand, P. Gobin, J. Brillault, S. Baptista, C. Adier et al., Aerosol Therapy with Colistin Methanesulfonate: a Biopharmaceutical Issue Illustrated in Rats, Antimicrobial Agents and Chemotherapy, vol.54, issue.9, pp.54-3702, 2010.
DOI : 10.1128/AAC.00411-10

K. Sugano, N. Takata, M. Machida, K. Saitoh, and K. Terada, Prediction of passive intestinal absorption using bio-mimetic artificial membrane permeation assay and the paracellular pathway model, International Journal of Pharmaceutics, vol.241, issue.2, pp.241-241, 2002.
DOI : 10.1016/S0378-5173(02)00240-5

D. E. Geller, M. W. Konstan, J. Smith, S. B. Noonberg, and C. Conrad, Novel tobramycin inhalation powder in cystic fibrosis subjects: Pharmacokinetics and safety, Pediatric Pulmonology, vol.95, issue.4, pp.42-307, 2007.
DOI : 10.1002/ppul.20594

S. B. Fiel, Aerosolized antibiotics in cystic fibrosis: an update. Expert review of respiratory medicine 2014, pp.305-314

. Steroid, mucokinetic hybrid nanoporous microparticles for pulmonary drug delivery, European Journal of Pharmaceutics and Biopharmaceutics, vol.2013, issue.853, pp.604-613

A. M. Healy, M. I. Amaro, K. J. Paluch, and L. Tajber, Dry powders for oral inhalation free of lactose carrier particles Advanced drug delivery reviews, pp.32-52, 2014.

R. Stahlmann and H. M. Lode, Risks associated with the therapeutic use of fluoroquinolones Tendon Injury and Fluoroquinolone Use: A Systematic Review, Expert Opinion on Drug Safety Drug Safety, vol.82, issue.1249, pp.196-201, 1987.

E. Guillot, I. Sermet, A. Ferroni, S. Chhun, G. Pons et al., Suboptimal ciprofloxacin dosing as a potential cause of decreased Pseudomonas aeruginosa susceptibility in children with cystic fibrosis, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, issue.12, pp.30-1252, 2010.

P. Bruinenberg, I. H. Gonda, B. Weimann, J. Nagelschmitz, W. V. De-castro et al., Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial Rolinck-Werninghaus, C.; Staab, D. Tolerability and pharmacokinetic properties of ciprofloxacin dry powder for inhalation in patients with cystic fibrosis: a Phase I, randomized, dose-escalation study Relative contributions of active mediated transport and passive diffusion of fluoroquinolones with various lipophilicities in a Calu-3 lung epithelial cell model, Thorax 2013. 15. Stass, pp.1571-1581, 2010.

J. P. Wong, H. Yang, K. L. Blasetti, G. Schnell, J. Conley et al., Liposome delivery of ciprofloxacin against intracellular Francisella tularensis infection, Journal of Controlled Release, vol.92, issue.3, pp.92-265, 2003.
DOI : 10.1016/S0168-3659(03)00358-4

S. Antoniu and D. Azoicai, Ciprofloxacin DPI in non-cystic fibrosis bronchiectasis: a Phase II randomized study, Expert Opinion on Investigational Drugs, vol.22, issue.5, pp.671-673
DOI : 10.1164/rccm.201005-0756OC

R. Wilson, T. Welte, E. Polverino, A. De-soyza, H. Greville et al., Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study Turel, I. The interactions of metal ions with quinolone antibacterial agents Uivarosi, V. Metal complexes of quinolone antibiotics and their applications: an update Complexes of Ciprofloxacin with Metal Ions Contained in Antacid Drugs Comparative study of the influence of Ca2+ on absorption parameters of ciprofloxacin and ofloxacin Metal cation?fluoroquinolone complexes do not permeate through the intestinal absorption barrier Effects of aluminum hydroxide and calcium carbonate antacids on the bioavailability of ciprofloxacin, Use of Aerosolized Antibiotics for Treating Chronic Obstructive Pulmonary Disease. Google Patents, pp.41-1107, 1992.

A. I. Caço, F. Varanda, M. J. Pratas-de-melo, A. M. Dias, and R. Dohrn, Marrucho, I. M. Solubility of antibiotics in different solvents

F. Ehrhardt, C. Healy, A. S. Jimenez-kairuz, A. F. Manzo, R. H. Olivera et al., Superparamagnetic iron oxide nanoparticles (SPIONs)-loaded Trojan microparticles for targeted aerosol delivery to the lung Solubility behavior and biopharmaceutical classification of novel high-solubility ciprofloxacin and norfloxacin pharmaceutical derivatives Advanced drug delivery reviews, Molecular Pharmaceutics European Journal of Pharmaceutics and Biopharmaceutics International journal of pharmaceutics Siepmann, J, vol.81, issue.322, pp.1887-1898, 2001.

J. Brillault, W. V. De-castro, T. Harnois, A. Kitzis, J. C. Olivier et al., P-glycoproteinmediated transport of moxifloxacin in a Calu-3 lung epithelial cell model Formulation of rifampicin-cyclodextrin complexes for lung nebulization, Antimicrob Agents Chemother Tewes, F.; Brillault, J.; Couet, J. Control. Release, vol.53, issue.342, pp.1457-62, 2008.

J. Arias, Polysaccharides and Proteoglycans in Calcium Carbonate-based Biomineralization, Chemical Reviews, vol.108, issue.11, pp.4475-4482, 2008.
DOI : 10.1021/cr078269p

B. M. Assael, Hyaluronic Acid Improves the Tolerability of Hypertonic Saline in the Chronic Treatment of Cystic Fibrosis Patients: A Multicenter, Randomized, Controlled Clinical Trial Journal of aerosol medicine and pulmonary drug delivery 2014, Turino, G. M.; Cantor, J. O. Hyaluronan in Respiratory Injury and Repair. American Journal of Respiratory and Critical Care Medicine, vol.27, issue.389, pp.133-137, 2003.

I. Aranaz, M. Gutiérrez, L. Yuste, F. Rojo, M. Ferrer et al., Controlled formation of the anhydrous polymorph of ciprofloxacin crystals embedded within chitosan scaffolds: study of the kinetic release dependence on crystal size, Journal of Materials Chemistry, vol.467, issue.11, pp.19-1576, 2009.
DOI : 10.1039/b813156b

X. Li, F. Zhi, Y. Hu, H. Matahwa, V. Ramiah et al., Investigation of excipient and processing on solid phase transformation and dissolution of ciprofloxacin Calcium carbonate crystallization in the presence of modified polysaccharides and linear polymeric additives Post-combustion CO2 capture by formic acid-modified CaO-based sorbents, International Journal of Pharmaceutics Journal of Crystal Growth International Journal of Greenhouse Gas Control, vol.328, issue.160, pp.177-182, 2007.

K. Saoo and K. Imaida, Lung toxicity of 16 fine particles on intratracheal instillation in a bioassay model using f344 male rats, Toxicologic pathology, vol.36, issue.4, pp.620-631, 2008.

I. Turel, P. Bukovec, and M. Quirós, Crystal structure of ciprofloxacin hexahydrate and its characterization, International Journal of Pharmaceutics, vol.152, issue.1, pp.59-65, 1997.
DOI : 10.1016/S0378-5173(97)04913-2

H. A. Al-hosney, S. Carlos-cuellar, J. Baltrusaitis, and V. H. Grassian, Heterogeneous uptake and reactivity of formic acid on calcium carbonate particles: a Knudsen cell reactor, FTIR and SEM study, Physical Chemistry Chemical Physics, vol.64, issue.20, pp.3587-3595, 2005.
DOI : 10.1029/2004JD005206

Y. Politi, T. Arad, E. Klein, S. Weiner, and L. Addadi, Sea Urchin Spine Calcite Forms via a Transient Amorphous Calcium Carbonate Phase, Science, vol.306, issue.5699, pp.1161-1164, 2004.
DOI : 10.1126/science.1102289

A. Al-sawalmih, C. Li, S. Siegel, P. Fratzl, and O. Paris, On the stability of amorphous minerals in lobster cuticle Sorption of the Antimicrobial Ciprofloxacin To Aluminum and Iron Hydrous Oxides, Advanced Materials Environmental Science & Technology, vol.21, issue.4023, pp.4011-4015, 2005.

G. Wu, G. Wang, X. Fu, L. O. Zhu, E. Bar-david et al., Synthesis, Crystal Structure, Stacking Effect and Antibacterial Studies of a Novel Quaternary Copper (II) Complex with Quinolone, Molecules, vol.8, issue.2, pp.287-296, 2003.
DOI : 10.3390/80200287

H. E. Newell, G. Buckton, D. A. Butler, F. Thielmann, and D. R. Williams, The use of inverse phase gas chromatography to measure the surface energy of crystalline, amorphous, and recently milled lactose, Pharmaceutical research, issue.5, pp.18-662, 2001.

J. Zhang, S. Ebbens, X. Chen, Z. Jin, S. Luk et al., Determination of the Surface Free Energy of Crystalline and Amorphous Lactose by Atomic Force Microscopy Adhesion Measurement, Pharmaceutical Research, vol.91, issue.2, pp.23-401, 2006.
DOI : 10.1007/s11095-005-9144-1

M. I. Amaro, L. Tajber, O. I. Corrigan, and A. M. Healy, Optimisation of spray drying process conditions for sugar nanoporous microparticles (NPMPs) intended for inhalation, International Journal of Pharmaceutics, vol.421, issue.1, pp.421-99, 2011.
DOI : 10.1016/j.ijpharm.2011.09.021

T. C. Carvalho, J. I. Peters, and R. O. Williams-iii, Influence of particle size on regional lung deposition ??? What evidence is there?, International Journal of Pharmaceutics, vol.406, issue.1-2, pp.406-407, 2011.
DOI : 10.1016/j.ijpharm.2010.12.040

D. Cipolla, H. Wu, S. Eastman, T. Redelmeier, I. Gonda et al., Development and Characterization of an In Vitro Release Assay for Liposomal Ciprofloxacin for Inhalation Aerosol Performance and Long-Term Stability of Surfactant-Associated Liposomal Ciprofloxacin Formulations with Modified Encapsulation and Release Properties Modifying matrix micro-environmental pH to achieve sustained drug release from highly laminating alginate matrices, European Journal of Pharmaceutics and Biopharmaceutics Journal of Pharmaceutical Sciences AAPS PharmSciTech European Journal of Pharmaceutical Sciences, vol.86, issue.155, pp.83-89, 2008.

P. H. Karp, C. L. Wohlford-lenane, H. P. Haagsman, M. Van-eijk, C. Stockmann et al., Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung 109-113. 61 Turel, I. X-Ray crystallographic, NMR and antimicrobial activity studies of magnesium complexes of fluoroquinolones ? racemic ofloxacin and its S-form, levofloxacin, Nature Clinical Pharmacokinetics of Inhaled Antimicrobials. Clinical Journal of Inorganic Biochemistry, vol.487, issue.10011, pp.473-492, 2006.

V. Claro, A. Mendes, and R. Ortiz, Fluoroquinolone-metal complexes: a route to counteract bacterial resistance, Journal of Inorganic Biochemistry, vol.138, pp.129-143, 2014.

G. Psomas, Neutral and cationic mononuclear copper(II) complexes with enrofloxacin: structure and biological activity Delcour, A. H. Outer membrane permeability and antibiotic resistance, Proteins and Proteomics, pp.1378-88, 2006.

H. Nikaido and D. Thanassi, Penetration of lipophilic agents with multiple protonation sites into bacterial cells: tetracyclines and fluoroquinolones as examples., Antimicrobial Agents and Chemotherapy, vol.37, issue.7, p.1393, 1993.
DOI : 10.1128/AAC.37.7.1393